News Details

Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division's digital transformation goals and accelerate its precision medicine and genomics research programs.

The MoU was signed by Dr. Khalid Fakhro, the Chief Research Officer from Sidra Medicine, and Lana Khalaf, General Manager of Microsoft Qatar.

The MoU includes a series of strategic collaborations and implementations that will enable Sidra Medicine's research division to expedite its technology and cloud adoption on Microsoft's platforms, towards a complete digital transformation.

Click on the news' source link to read the full story.